Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06230731 · ClinicalTrials.gov registry record · NA
Oxygenation in Vascular Lesions of the Colon
A NA study of Vascular Lesion, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06230731: Recruiting NA study of Vascular Lesion, sponsored by University of Chicago.
NCT06230731 is a NA study of Vascular Lesion that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06230731, a NA study of Vascular Lesion, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.
Primary Outcome
Colonic oxygen saturation levels will be compared between patients with vascular lesions of the colon and healthy controls.
Conditions Studied
Interventions
- OTHER Oxygen saturation
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2029-02-01 |
| Phase | NA |
What NCT06230731 shows while recruiting
NCT06230731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Vascular Lesion appearing as the primary indexed condition, and to 1 intervention - of which Oxygen saturation is the first listed.
NCT06230731 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06230731 about?
NCT06230731 is a clinical study titled "Oxygenation in Vascular Lesions of the Colon". The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.
What is the current status of trial NCT06230731?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-02-01. Estimated completion is 2029-02-01.
What conditions does trial NCT06230731 study?
This clinical trial studies the following conditions: Vascular Lesion.
What interventions are being tested in trial NCT06230731?
The interventions under investigation include: Oxygen saturation (OTHER).
Who is sponsoring clinical trial NCT06230731?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06230731 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06230731's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI